Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
22.64
+0.16 (0.71%)
May 11, 2026, 4:08 PM HKT

HKG:2190 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,057782.48527.75334.09177.91
Revenue Growth (YoY)
35.15%48.27%57.97%87.78%543.88%
Cost of Revenue
294.57222.58142.7781.4246.03
Gross Profit
762.92559.9384.99252.67131.88
Selling, General & Admin
315.88265.76277.92249.47195.87
Research & Development
246.78233.23261.01233.46168.1
Other Operating Expenses
1.452.11.6-6.78-13.94
Operating Expenses
564.1501.13540.54476.18350.05
Operating Income
198.8258.77-155.55-223.51-218.17
Interest Expense
-1.02-2.18-1.25-0.72-0.31
Interest & Investment Income
59.1967.3579.0495.5713.09
Earnings From Equity Investments
--1.1---
Currency Exchange Gain (Loss)
-7.161.51-0.2619.63-8.28
Other Non Operating Income (Expenses)
-12.3512.178.4--
EBT Excluding Unusual Items
237.48136.51-69.63-109.04-213.66
Gain (Loss) on Sale of Investments
-0.65-36.21-8.514.8113.95
Gain (Loss) on Sale of Assets
-0.09-0.05-0.59-9.320.02
Pretax Income
236.74100.26-78.73-113.56-199.69
Income Tax Expense
-7.63----
Net Income
244.37100.26-78.73-113.56-199.69
Net Income to Common
244.37100.26-78.73-113.56-199.69
Net Income Growth
143.75%----
Shares Outstanding (Basic)
320323329330295
Shares Outstanding (Diluted)
324328329330295
Shares Change (YoY)
-1.34%-0.22%-0.51%12.15%51.26%
EPS (Basic)
0.760.31-0.24-0.34-0.68
EPS (Diluted)
0.760.31-0.24-0.34-0.68
EPS Growth
147.04%----
Free Cash Flow
273.64-17.26-92.48-226.06-194.32
Free Cash Flow Per Share
0.85-0.05-0.28-0.68-0.66
Dividend Per Share
0.2200.100---
Dividend Growth
120.00%----
Gross Margin
72.14%71.55%72.95%75.63%74.13%
Operating Margin
18.80%7.51%-29.48%-66.90%-122.63%
Profit Margin
23.11%12.81%-14.92%-33.99%-112.24%
Free Cash Flow Margin
25.88%-2.21%-17.52%-67.66%-109.22%
EBITDA
232.2491.44-126.44-203.47-208.49
EBITDA Margin
21.96%11.68%-23.96%-60.90%-117.18%
D&A For EBITDA
33.4232.6729.1120.049.68
EBIT
198.8258.77-155.55-223.51-218.17
EBIT Margin
18.80%7.51%-29.48%-66.90%-122.63%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.